Form D · Biotechnology
Ecovatec Solutions Inc.
Vancouver, A1 · CIK 0001657734
Offering snapshot reported Nov 25, 2015 · SEC filing
- Reported sold
- $0 Offering amount: $18.9K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2015 | Initial | $0 | No comparison | 2 | SEC filing |
| Nov 5, 2015 | Initial | $4,298 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $564 (estimated)
- Finders' fees
- $0
- Form D file number
- 021-251925
US dollar amounts are based on the Bank of Canada noon rate of exchange reported on November 4, 2015 for $15,625(CDN) which was US$0.7596 = CDN$1.00 and November 9, 2015 for $9,375(CDN) which was US$0.7533 = CDN$1.00.
Commission was paid on the November 9, 2015 subscription of US$7,062.19. The US dollar amount is based on the Bank of Canada noon rate of exchange reported on November 9, 2015 of US$0.7533 = CDN$1.00.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Haywood Securities (USA) Inc. | 42072 | Haywood Securities Inc. |
Source: Form D, filed Nov 25, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick Elliott | Executive |
| Peter Alexander Hogendoorn | Director, Executive |
| William Andrew Perrin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1588 609 Granville Street
Vancouver, A1, V7Y 1G5
Vancouver, A1, V7Y 1G5